{"id":12446,"date":"2019-11-15T16:28:20","date_gmt":"2019-11-15T15:28:20","guid":{"rendered":"https:\/\/www.mannheimerswartling.se\/?p=12446"},"modified":"2021-03-10T16:18:48","modified_gmt":"2021-03-10T15:18:48","slug":"mesa-laboratories-forvarvar-gyros-protein-technologies","status":"publish","type":"post","link":"https:\/\/www.mannheimerswartling.se\/uppdrag\/mesa-laboratories-forvarvar-gyros-protein-technologies\/","title":{"rendered":"Mesa Laboratories f\u00f6rv\u00e4rvar Gyros Protein Technologies"},"content":{"rendered":"<p>Mesa Laboratories Inc. har f\u00f6rv\u00e4rvat 100% av aktierna i Gyros Protein Technologies AB f\u00f6r en total k\u00f6peskilling om 180 miljoner USD med f\u00f6rbeh\u00e5ll f\u00f6r k\u00f6peskillingsjustering. Gyros Protein Technologies f\u00f6rv\u00e4rvades fr\u00e5n Sj\u00e4tte AP-fonden (genom SLS Invest AB), Ampersand Capital Partners samt diverse minoritetsaktie\u00e4gare.<\/p>\n<p>Gyros Protein Technologies, med huvudkontor i Uppsala \u00e4r en ledande leverant\u00f6r av immunanalys och peptidsyntesl\u00f6sningar som driver innovation, utveckling och tillverkning av biofarmaceutiska l\u00e4kemedel.<\/p>\n<p>Mesa \u00e4r en global teknologisk innovat\u00f6r som \u00e4r dedikerade \u00e5t att l\u00f6sa n\u00e5gra av de mest kritiska utmaningarna g\u00e4llande kvalitetskontroll inom sjukv\u00e5rds-, industriell s\u00e4kerhets-, milj\u00f6-, mat och dryck- samt l\u00e4kemedelsindustrin.<\/p>\n<p>Mesa r\u00e5dgavs av Mannheimer Swartling i transaktionen tillsammans med den amerikanska advokatbyr\u00e5n David Graham &amp; Stubbs.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mesa Laboratories Inc. har f\u00f6rv\u00e4rvat 100% av aktierna i Gyros Protein Technologies AB f\u00f6r en total k\u00f6peskilling om 180 miljoner USD med f\u00f6rbeh\u00e5ll f\u00f6r k\u00f6peskillingsjustering.\u2026<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3469],"tags":[],"class_list":["post-12446","post","type-post","status-publish","format-standard","hentry","category-uppdrag","business-group-corporate-sustainability-risk-management","business-group-foretagsoverlatelser"],"acf":[],"lang":"sv","translations":{"sv":12446,"en":12448},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12446"}],"collection":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/comments?post=12446"}],"version-history":[{"count":2,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12446\/revisions"}],"predecessor-version":[{"id":14308,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12446\/revisions\/14308"}],"wp:attachment":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media?parent=12446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/categories?post=12446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/tags?post=12446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}